Regulatory29 Aug 2026, 03:00 pm
Sudarshan Pharma Files FY26 Annual Report
AI Summary
Sudarshan Pharma Industries Ltd has filed its Annual Report for the Financial Year 2025-26, in compliance with Regulation 34 of SEBI Listing Regulations. The report is being disseminated electronically to shareholders. It includes sections on Corporate Overview, Statutory Reports, and Financial Statements, covering both standalone and consolidated financials. The company also provided a forward-looking statement disclaimer regarding potential risks and uncertainties.
Key Highlights
- Annual Report for FY 2025-26 filed as per SEBI regulations.
- Report includes corporate information, chairman's and MD's messages.
- Financial statements cover standalone and consolidated data.
- Forward-looking statements included with risk disclaimers.
- Electronic distribution to shareholders whose emails are registered.
Price Impact
More from SUDARSHAN